Jolynn Tumolo

News

06/01/2021

Jolynn Tumolo

Sigmapharm Laboratories is voluntarily recalling 15,052 bottles of asenapine sublingual tablets because they were manufactured using cherry flavoring instead of black cherry flavoring.

Sigmapharm Laboratories is...

06/01/2021

Pharmacy Learning Network

News

Subpotent Antibiotic Recalled

06/01/2021

Jolynn Tumolo

A Class II recall is active for a prescription antibiotic used to treat a variety of bacterial infections, including uncomplicated urinary tract infections, otitis media, and pharyngitis and tonsillitis.

A Class II recall is active for...

06/01/2021

Pharmacy Learning Network

News

Multidisciplinary Stakeholders Provide Input on Improving End-of-Life Care

06/01/2021

Jolynn Tumolo

“Administrators should explore opportunities to reconfigure long-term care culture through communication changes, as well as the physical environment through facility design modifications,” researchers wrote.

“Administrators should explore...

06/01/2021

Annals of Long-Term Care

News

Therapy Produces Durable Responses in Patients With R/R DLBCL

06/01/2021

Jolynn Tumolo

“Loncastuximab tesirine has substantial single-agent antitumor activity and produces durable responses with an acceptable safety profile,” researchers concluded, “potentially offering a new therapeutic option for heavily pretreated patients...

“Loncastuximab tesirine has...

06/01/2021

First Report Managed Care

News

No Link Between Psoriasis and Non-Ischemic Dilated Cardiomyopathy

06/01/2021

Jolynn Tumolo

Despite case reports and small observational studies that have suggested a link between psoriasis and non-ischemic dilated cardiomyopathy, a new population-based cross-sectional study failed to find such an association.

Despite case reports and small...

06/01/2021

First Report Managed Care

News

Nearly 1 in 5 Emergency Department Prescriptions Yield Pharmacist Intervention

06/01/2021

Jolynn Tumolo

“When necessary, emergency medicine pharmacists discussed recommendations with prescribers, or adjusted prescriptions according to institutional pharmacist privileges,” wrote researchers.

“When necessary, emergency...

06/01/2021

Pharmacy Learning Network

News Connection

Neurologic Adverse Events From DLBCL Treatment Boost Health Care

05/28/2021

Jolynn Tumolo

Neurologic toxicities from treatment for relapsed or refractory diffuse large B-cell lymphoma (DLBCL) increased total health care costs more than $70,000 on average for US patients, according to a study published recently in American Health &...

Neurologic toxicities from...

05/28/2021

First Report Managed Care

News

Costs High for Both SMA Standard Care and Newer Treatments for Post-Symptomatic Patients

04/19/2021

Jolynn Tumolo

The cost burden of standard of care for patients with spinal muscular atrophy is substantial, and at current prices approved disease-modifying drugs for the condition have high cost-effectiveness ratios when delivered after symptom onset.

The cost burden of standard of...

04/19/2021

First Report Managed Care

News

Psychedelic Therapy Offers a Synergy of Biological, Psychosocial Interventions

07/26/2020

Jolynn Tumolo

Psychedelic therapy unites two basic, and often opposing, views as to the best approach to mental health treatment, Robin Carhart-Harris, PhD, explained at the 2020 virtual Psych Congress Elevate conference.

Psychedelic therapy unites two...

07/26/2020

Psych Congress Network

Research in Review

‚ÄòBasket Study‚Äô Shows Treatment Response in Certain Patients with Advanced Lung Cancer

09/17/2015

Jolynn Tumolo

Citations: Hyman DM, Puzanov I, Subbiah V, et al. Vemurafenib in multiple nonmelanoma cancers with BRAF V600 mutations. New Engl J Med. 2015;373:726–736. More than one-third of patients with advanced lung...

...

09/17/2015

Journal of Clinical Pathways